Thromb Haemost 1988; 60(02): 305-307
DOI: 10.1055/s-0038-1647049
Original Article
Schattauer GmbH Stuttgart

In Vitro Inhibition of Urokinase by Penicillins

Abd Al-Roof Higazi
The Department of Clinical Biochemistry, Hadassah-Hebrew University Medical School, Mount Scopus Hospital, Jerusalem, Israel
,
Michael Mayer
The Department of Clinical Biochemistry, Hadassah-Hebrew University Medical School, Mount Scopus Hospital, Jerusalem, Israel
› Author Affiliations
Further Information

Publication History

Received 25 November 1987

Accepted after revision 27 June 1988

Publication Date:
23 July 2018 (online)

Summary

Urokinase activity was assayed by a two-stage globinolytic method and by a direct chromogenic assay. With both methods, the enzyme activity was found to be inhibited by penicillins. The inhibition by penicillin G, carbenicillin, cloxacillin and penicilloic acid was dose-dependent. The Kj of penicillin G and urokinase with the S-2444 as substrate is 4 mM. This compound exhibited a competitive pattern of inhibition. Ampicillin and 6-amino penicillanic acid failed to inhibit urokinase. These results imply that hydrophobic side chains of penicillins interact with the active site of urokinase. The present observation could be relevant in clinical situation in which high doses of beta-lactam antibiotics could modulate the endogenous fibrinolytic activity of circulating urokinase.

 
  • References

  • 1 Collen D. On the regulation and control of fibrinolysis. Thromb Haemostas 1980; 43: 77-89
  • 2 Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators tissue, degradation and cancer. Adv Cane Res 1985; 44: 139-266
  • 3 Saksela O. Plasminogen activation and regulation of pericellular proteolysis. Biochim Biophys Acta 1985; 823: 35-65
  • 4 Busso N, Belin D, Failly-Crepin C, Vassalli JD. Plasminogen activator and their inhibitors in a human mammary cell line (HBL- 100). J Biol Chem 1986; 20: 9309-9315
  • 5 Juhan-Vague I, Ailland MF, Serradimigni A. Natural inhibitors of fibrinolysis. Haemostasis 1986; 3: 16-20
  • 6 Astedt B, Holmberg L, Nilsson IM. An inhibitor of plasminogen activator in pregnancy plasma. In: Progress in Fibrinolysis (; Vol VII.). Davidson JF, Donati MB, Coccheri S. (eds) Churchill Livingstone; New York: 1985: 122-125
  • 7 Kruithof EKO, Gudinchet AL, Tran-Thang C, Ransijin A, Bachmann F. In: Progress in Fibrinolysis. (; Vol. VII.). Davidson JF, Donati MB, Coccheri S. (eds) Churchill Livingstone; New York: 1985: 130-132
  • 8 Cwikel BJ, Barouski-Miller PA, Coleman PL, Gelehrter TD. Dexamethasone induction of an inhibitor of plasminogen activator in HTC hepatoma cells. J Biol Chem 1984; 259: 6847-6851
  • 9 Mayer M, Finci Z, Chaouat M. Suppression of plasminogen activator activity by dexamethasone in cultured cardiac myocytes. J Mol Cell Cardiol 1986; 18: 1117-1124
  • 10 Deutsch DG, Mertz ET. Plasminogen: Purification from human plasma by affinity chromatography. Science 1970; 170: 1095-1096
  • 11 Roth JS, Losty T, Wierbicki E. Assay of proteolytic enzyme activity using a 14C-labeled hemoglobin. Anal Biochem 1971; 42: 214-221
  • 12 Finzi Z, Nachshon I, Sharoni Y, Mayer M. A functional assay of plasminogen activator by hydrolysis of 14C-globin. Exp Hematol 1986; 14: 293-297
  • 13 Dano K, Reich E. Plasminogen activator from cells transformed by an oncogenic virus. Inhibitors of the activation reaction. Biochim Biophys Acta 1979; 566: 138-151
  • 14 Ballard JO, Barnes SG, Saffler FR. Comparation of the effects of metacillin carbenicillin and placebo on normal hemostasis. Antimicrob Agents Chemother 1984; 25: 153-156
  • 15 Mandell GL, Sande MA. Antimicrobial agents (The penicillins). In: The Pharmacological Basis of Therapeutics. 6th Goodman LS, Gilman A. (eds) Macmillan Publishing Co., Inc; New York: 1980: 1133
  • 16 Neu HC. B-lactam antibiotics: structural relationships affecting in vitro activity and pharmacologic properties. Reviews of Infectious Diseases. (; Vol. 8). Supplement 3. July-August 1986: S237-59
  • 17 Fletcher C, Pearson C, Choi SC, Dumas RJ, Evans HJ, Qureshi CD. In vitro comparison of antiplatelet effects of beta-lactam penicillins. J Lab Clin Med 1986; 108: 217-223
  • 18 Mihara S, Fujimoto M, Okabayashi T. Suppression of beta-lactam antibiotics of thromboxane A2 generation and arachidonic acid release in rabbit platelets in vitro. Thromb Res 1986; 44: 265-275